#1 Clinical Trials Search in Europe

Perindopril Tert-Butylamine

This article explores recent clinical trials investigating the bioequivalence and safety of Perindopril Tert-Butylamine, a medication used to treat high blood pressure and heart failure. These studies compare different formulations and combinations of Perindopril Tert-Butylamine with other drugs, assessing their effectiveness and safety in healthy volunteers. The trials aim to determine if new generic versions of the medication are as effective as existing brand-name versions, potentially leading to more affordable treatment options for patients.

Table of Contents

What is Perindopril Tert-Butylamine?

Perindopril Tert-Butylamine is a medication that belongs to a class of drugs called angiotensin-converting enzyme (ACE) inhibitors. It is used to treat various cardiovascular conditions, primarily high blood pressure (hypertension) and heart failure[1]. This medication is also known by its brand name ACERTIL®, and it may be available in different formulations, such as tablets[2].

Medical Uses

Perindopril Tert-Butylamine is primarily used to treat:

  • High Blood Pressure (Hypertension): This medication helps lower blood pressure by relaxing blood vessels, making it easier for the heart to pump blood throughout the body[3].
  • Heart Failure: It can help improve heart function in patients with heart failure, a condition where the heart cannot pump blood effectively[3].

How It Works

Perindopril Tert-Butylamine works by inhibiting an enzyme called angiotensin-converting enzyme (ACE). This enzyme is responsible for producing a substance called angiotensin II, which causes blood vessels to narrow. By blocking this enzyme, Perindopril helps blood vessels relax and widen, leading to lower blood pressure and improved blood flow[3].

Dosage and Administration

The typical dosage of Perindopril Tert-Butylamine is 4 mg, taken orally once daily. However, the exact dosage may vary depending on the patient’s condition and response to treatment. In clinical studies, the medication was administered as follows:

  • A single oral dose of 4 mg, taken with 240 mL of warm water[1].
  • The medication can be taken on an empty stomach or after meals, depending on the doctor’s instructions[1][2].

It’s important to follow your doctor’s instructions carefully and not to change your dosage without consulting them first.

Combination Therapies

Perindopril Tert-Butylamine is sometimes combined with other medications to enhance its effectiveness in treating hypertension and heart-related conditions. Some common combinations include:

  • Perindopril Tert-Butylamine with Indapamide: This combination includes a thiazide-like diuretic (indapamide) to help remove excess fluid from the body, further lowering blood pressure[3].
  • Perindopril Tert-Butylamine with Indapamide and Amlodipine: This triple combination adds a calcium channel blocker (amlodipine) to provide additional blood pressure control and treat coronary artery disease[4].

Bioequivalence Studies

Several studies have been conducted to compare different formulations of Perindopril and ensure they work similarly in the body. These studies, called bioequivalence studies, help determine if generic versions of the medication are as effective as the brand-name versions. Key points from these studies include:

  • Comparisons between Perindopril Tert-Butylamine and Perindopril Arginine formulations[3].
  • Evaluations of how the medication is absorbed and processed by the body when taken on an empty stomach or after meals[1][2].
  • Measurements of maximum drug concentration (Cmax) and area under the plasma concentration versus time curve (AUC) to assess how much of the drug enters the bloodstream and how long it stays active[3][4].

Safety and Side Effects

While Perindopril Tert-Butylamine is generally considered safe and effective, like all medications, it may cause side effects in some patients. Clinical trials have included safety assessments to monitor for potential adverse effects. These assessments typically involve:

  • Vital signs examinations
  • Physical examinations
  • Laboratory safety tests
  • Coagulation examinations
  • Electrocardiogram (ECG) monitoring
  • Adverse event reporting[1][2]

It’s important to report any unusual symptoms or side effects to your healthcare provider. They can help determine if these effects are related to the medication and advise on the best course of action.

Aspect Details
Study Types Bioequivalence studies, randomized, open-label, crossover designs
Medications Studied Perindopril Tert-Butylamine (alone and in combinations)
Combination Drugs Perindopril Tert-Butylamine with Indapamide and/or Amlodipine
Main Outcomes Measured Maximum drug concentration (Cmax), Area under the curve (AUC)
Study Participants Healthy adult volunteers
Administration Conditions Fasting and after meals
Safety Assessments Vital signs, physical exams, lab tests, adverse event monitoring
Potential Benefits Development of generic alternatives, potentially lower treatment costs

FAQ

  • What is Perindopril Tert-Butylamine? Perindopril Tert-Butylamine is a medication belonging to the class of angiotensin-converting enzyme (ACE) inhibitors. It is used to treat high blood pressure (hypertension) and heart failure.
  • What is the purpose of bioequivalence studies? Bioequivalence studies aim to determine if a generic version of a medication has the same effectiveness and safety profile as the brand-name version. This helps ensure that patients can receive equally effective treatment with potentially more affordable generic options.
  • How are these clinical trials conducted? These trials typically involve healthy volunteers who are given either the test medication (generic version) or the reference medication (brand-name version) in a randomized order. Blood samples are taken at various time points to measure the concentration of the drug in the body.
  • What are the main outcomes measured in these trials? The main outcomes measured include the maximum concentration of the drug in the blood (Cmax) and the area under the concentration-time curve (AUC), which represents the total exposure to the drug over time. These measurements help determine if the generic version behaves similarly to the brand-name version in the body.
  • Are there any combination drugs being studied with Perindopril Tert-Butylamine? Yes, some trials are studying combinations of Perindopril Tert-Butylamine with other medications such as indapamide (a diuretic) and amlodipine (a calcium channel blocker). These combination drugs are used to treat high blood pressure when a single medication is not sufficient.

Ongoing Clinical Trials on Perindopril Tert-Butylamine

  • Study of stopping heart failure medications in patients with non-ischemic cardiomyopathy who responded very well to cardiac resynchronization therapy

    Recruiting

    1 1 1 1
    Investigated drugs:
    Spain

  • Study on Stopping Beta-Blockers in Heart Failure Patients with Recovered Heart Function Using Carvedilol and Drug Combination

    Recruiting

    1 1 1 1
    Investigated drugs:
    France

  • Study on the Effects of Perindopril, Valsartan, and Glyceryl Trinitrate in Women with Asymptomatic Heart Failure

    Recruiting

    1 1 1 1
    Investigated diseases:
    Investigated drugs:
    The Netherlands

  • Study on Preventing Heart Disease in Diabetes Patients Using Eprosartan Mesilate and Drug Combination

    Not yet recruiting

    1 1 1 1
    Investigated drugs:
    Austria Spain

  • Study of XXB750 and Drug Combination for Patients with Heart Failure

    Not recruiting

    1 1
    Investigated drugs:
    Bulgaria Czechia Denmark France Germany Hungary +5

  • Study on the Effects of Metoprolol, Prasugrel, and Carbasalate Calcium in Patients with Spontaneous Coronary Artery Dissection

    Not recruiting

    1 1 1 1
    Investigated diseases:
    Investigated drugs:
    Spain

Glossary

  • Bioequivalence: The property of two drug products having the same active ingredient, dosage form, strength, and route of administration, which demonstrate similar bioavailability and produce the same effect at the site of action.
  • ACE inhibitor: Angiotensin-Converting Enzyme inhibitor, a type of medication that helps relax blood vessels and lower blood pressure by blocking the action of a hormone that narrows blood vessels.
  • Cmax: The maximum concentration of a drug in the blood after it has been administered, usually measured in pharmacokinetic studies.
  • AUC: Area Under the Curve, a measure of the total exposure to a drug over time, calculated from the concentration-time curve in pharmacokinetic studies.
  • Pharmacokinetics: The study of how a drug moves through the body, including its absorption, distribution, metabolism, and excretion.
  • Washout period: A period of time between different treatments in a clinical trial, allowing the effects of the previous treatment to wear off before starting the next one.
  • Crossover design: A type of clinical trial where participants receive different treatments in a specific order, allowing each person to serve as their own control.
  • Indapamide: A thiazide-like diuretic medication used to treat high blood pressure and fluid retention.
  • Amlodipine: A calcium channel blocker medication used to treat high blood pressure and certain types of chest pain (angina).

References

  1. https://clinicaltrials.gov/study/NCT04556110
  2. https://clinicaltrials.gov/study/NCT04556058
  3. https://clinicaltrials.gov/study/NCT05464745
  4. https://clinicaltrials.gov/study/NCT05470764